NeuroNascent

About:

Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.

Website: http://www.neuronascent.com

Top Investors: National Institute on Aging, Maryland Department of Business and Economic Development

Description:

Neuronascent discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression, neurodegenerative diseases, including Alzheimer's and Parkinson's, and Down syndrome. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD.